Published in
American Chemical Society, Journal of Medicinal Chemistry, 18(61), p. 8186-8201, 2018
DOI: 10.1021/acs.jmedchem.8b00518
Links
Tools
Discovery of TRPM8 Antagonist (S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine
Journal article published in 2018 by
Daniel B. Horne 
,
Kaustav Biswas ,
James Brown,
Michael D. Bartberger ,
Jeffrey Clarine,
Carl D. Davis,
Vijay K. Gore,
Scott Harried,
Michelle Horner,
Matthew R. Kaller,
Sonya G. Lehto,
Qingyian Liu,
Vu V. Ma,
Holger Monenschein,
Thomas T. Nguyen
and other authors.
,
Kaustav Biswas ,
James Brown,
Michael D. Bartberger ,
Jeffrey Clarine,
Carl D. Davis,
Vijay K. Gore,
Scott Harried,
Michelle Horner,
Matthew R. Kaller,
Sonya G. Lehto,
Qingyian Liu,
Vu V. Ma,
Holger Monenschein,
Thomas T. Nguyen
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving allowed
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Postprint:
archiving restricted
- Must obtain written permission from Editor
- Must not violate ACS ethical Guidelines
Published version:
archiving forbidden
Data provided by 